Antituberculosis effect of levofloxacin
Abstract
OBJECTIVE: Assess the activities of levofloxacin (LVLX) against Mycobacterium tuberculosis both in vitro and in vivo, the pharmacokinetics of LVLX and the effectiveness and safety of it in the treatment of pulmonary tuberculosis, with ofloxacin(OFLX) as control.
METHODS: The MIC and MBC of LVLX were determined by the tube doubling dilution method, and the effectiveness of the drugs were assessed by half survival time of the mice. The concentrations of LVLX and OFLX in serum were measured by HPLC. The pharmacokinetic parameters obtained were calculated. 138 newly diagnosed and retreatment pulmonary tuberculosis patients were randomly allocated to receive four chemotherapy regimens.
RESULTS: The MIC and MBC of LVLX against Mycobacterium tuberculosis were 2 dilutions lower than that of OFLX, in a murine tuberculosis model, the antimycobacterial activity of LVLX was significant and superior to OFLX with the same dose. The concentration-time curves of LVLX and OFLX were conformed to an one-compartment model. There was no significant difference between the two formulations in the Tmax, T1/2 and 1/2 Cmax, 1/2 AUC of OFLX and LVLX. The sputum conversion rates at the end of treatments of groups I, II, III and IV were 97%, 97%, 82% and 84% respectively. X-ray resolution rates were 97%, 94%, 88% and 88% respectively. The side effects of four groups were rather low.
CONCLUSIONS: LVLX displays powerful activities against Mycobacterium tuberculosis both in vitro and in vivo, which is two…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.